SELLAS Life Sciences Gr Analyst Ratings
SELLAS Life Sciences Gr Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/15/2022 | 213.73% | Alliance Global Partners | $14 → $8 | Maintains | Buy |
| 06/28/2022 | 135.29% | Cantor Fitzgerald | $10 → $6 | Maintains | Overweight |
| 07/21/2021 | 605.88% | Cantor Fitzgerald | → $18 | Initiates Coverage On | → Overweight |
| 11/15/2019 | 370.59% | Maxim Group | → $12 | Upgrades | Hold → Buy |
| 04/08/2019 | 76.47% | Alliance Global Partners | → $4.5 | Initiates Coverage On | → Buy |
| 11/01/2018 | 409.8% | Oppenheimer | → $13 | Initiates Coverage On | → Outperform |
| 07/20/2018 | 96.08% | Maxim Group | $13 → $5 | Maintains | Buy |
| 04/02/2018 | 331.37% | HC Wainwright & Co. | → $11 | Initiates Coverage On | → Buy |
| 03/19/2018 | — | Maxim Group | Upgrades | Hold → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 11/15/2022 | 213.73% | 聯盟全球合作伙伴 | $14 → $8 | 維護 | 買 |
| 06/28/2022 | 135.29% | 康託·菲茨傑拉德 | $10 → $6 | 維護 | 超重 |
| 07/21/2021 | 605.88% | 康託·菲茨傑拉德 | → $18 | 開始承保 | →超重 |
| 11/15/2019 | 370.59% | Maxim集團 | → $12 | 升級 | 持有→購買 |
| 04/08/2019 | 76.47% | 聯盟全球合作伙伴 | → $4.5 | 開始承保 | →購買 |
| 11/01/2018 | 409.8% | 奧本海默 | → $13 | 開始承保 | →跑贏大盤 |
| 07/20/2018 | 96.08% | Maxim集團 | $13 → $5 | 維護 | 買 |
| 04/02/2018 | 331.37% | HC Wainwright公司 | → $11 | 開始承保 | →購買 |
| 03/19/2018 | — | Maxim集團 | 升級 | 持有→購買 |
What is the target price for SELLAS Life Sciences Gr (SLS)?
Sellas Life Science Gr(SLS)的目標價是多少？
The latest price target for SELLAS Life Sciences Gr (NASDAQ: SLS) was reported by Alliance Global Partners on November 15, 2022. The analyst firm set a price target for $8.00 expecting SLS to rise to within 12 months (a possible 213.73% upside). 2 analyst firms have reported ratings in the last year.
聯盟全球合作伙伴於2022年11月15日報道了塞拉斯生命科學Gr(納斯達克：SLS)的最新目標價。這家分析公司將目標價定為8美元，預計SLS將在12個月內升至(可能上漲213.73%)。去年有兩家分析公司公佈了評級。
What is the most recent analyst rating for SELLAS Life Sciences Gr (SLS)?
Sellas Life Science Gr(SLS)的最新分析師評級是多少？
The latest analyst rating for SELLAS Life Sciences Gr (NASDAQ: SLS) was provided by Alliance Global Partners, and SELLAS Life Sciences Gr maintained their buy rating.
賽拉斯生命科學Gr(納斯達克代碼：SLS)的最新分析師評級由Alliance Global Partners提供，賽拉斯生命科學Gr維持買入評級。
When is the next analyst rating going to be posted or updated for SELLAS Life Sciences Gr (SLS)?
Sellas Life Science Gr(SLS)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SELLAS Life Sciences Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SELLAS Life Sciences Gr was filed on November 15, 2022 so you should expect the next rating to be made available sometime around November 15, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閲公共財務報表，與Sellas Life Science Gr的高管和客户交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Sellas Life Science Gr的上一次評級是在2022年11月15日提交的，所以你應該預計下一次評級將在2023年11月15日左右的某個時候提供。
Is the Analyst Rating SELLAS Life Sciences Gr (SLS) correct?
分析師對Sellas Life Science Gr(SLS)的評級正確嗎？
While ratings are subjective and will change, the latest SELLAS Life Sciences Gr (SLS) rating was a maintained with a price target of $14.00 to $8.00. The current price SELLAS Life Sciences Gr (SLS) is trading at is $2.55, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Sellas Life Science Gr(SLS)評級保持不變，目標價在14.00美元至8.00美元之間。Sellas Life Science Gr(SLS)目前的交易價格為2.55美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。